Sign in
Download Opera News App

STOCK INVESTMENT

Illumina is Committed to Bringing Lifesaving GRAIL Test to People Globally as European Review Process Enters Second Phase

Illumina is Committed to Bringing Lifesaving GRAIL Test to People Globally as European Review Process Enters Second Phase

Illumina, Inc. (NASDAQ:ILMN) today affirmed its commitment to re-acquire GRAIL, a healthcare company focused on multi-cancer early detection. "This acquisition is procompetitive, and we have offered far-reaching structural and behavioral remedies to address any potential concerns. Illumina will continue to work with the European Commission (EC) to ensure that...

Read Full Story
Charles Dadswell EC European Commission ILMN Illumina Inc

Top News

HOMEPAGE

Simone Biles withdraws from vault and bars, may still compete on floor and beam

foxnews.com
Simone Biles withdraws from vault and bars, may still compete on floor and beam

HOMEPAGE

Simone Biles withdraws from vault and bars, may still compete on floor and beam

foxnews.com

US POLITICS

White House: National vaccine mandate 'not under consideration at this time'

thehill.com
White House: National vaccine mandate 'not under consideration at this time'

US POLITICS

White House: National vaccine mandate 'not under consideration at this time'

thehill.com

comments

Load app to read more comments